REG - Hill & Smith Hdgs. - Director/PDMR Shareholding

Hill & SmithAnnouncement

08/04/2019 15:00

RNS Number : 4800V
Hill & Smith Hldgs PLC
08 April 2019
 


8 April 2019
Hill & Smith Holdings PLC
 
Notification under paragraphs 3.1.2R to 3.1.4R of the Disclosure and Transparency Rules
 
Hill & Smith Holdings PLC ('Hill & Smith' or the 'Company') announces that it has today been notified that Mr Mark Pegler, a person discharging managerial responsibilities of Hill & Smith has sold 4,215 ordinary shares in the Company at 1264.00 pence per share:
 



1.


Details of the person discharging managerial responsibilities/person closely associated




(a)


Name


Mr M Pegler




2.


Reason for the notification




(a)


Position/status


Group Finance Director




(b)


Initial notification/ Amendment


Initial notification




3.


Details of the issuer




(a)


Name


Hill & Smith Holdings PLC




(b)


LEI


 2138003A3ISGQZBOWI83




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




(a)


Description of the Financial Instrument


Ordinary shares of £0.25 each




(b)


Identification code of the Financial Instrument


GB0004270301




(c)


Nature of the transaction


Sale




(d)


Price(s) and volume(s)


Price(s)


Volume(s)




 


 


£12.64


4,215




(e)


Aggregated information
-              Aggregated volume
-              Price


 
4,215 shares
 
£12.64




(f)


Date of the transaction


5 April 2019




(g)


Place of the transaction


London Stock Exchange



 
Enquiries:
Alex Henderson
Company Secretary
Hill & Smith Holdings PLC
Tel: +44 (0) 121 704 7430




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFEVSDITIIA